RT Book, Section
A1 Brown, Jubilee
A2 Kantarjian, Hagop M.
A2 Wolff, Robert A.
SR Print(0)
ID 1126744229
T1 Gestational Trophoblastic Disease
T2 The MD Anderson Manual of Medical Oncology, 3e
YR 2016
FD 2016
PB McGraw-Hill Medical
PP New York, NY
SN 9780071847940
LK hemonc.mhmedical.com/content.aspx?aid=1126744229
RD 2024/04/18
AB Gestational  trophoblastic  disease  (GTD)  comprises  a  wide  spectrum  of  neoplastic  disorders  that  arise  from  placental  trophoblastic  tissue  after  abnormal  fertilization  (Fig.  34-1).  The  spectrum  includes  benign  disease  (complete  and  partial  hydatidiform  moles)  and  malignant  gestational  trophoblastic  neoplasia  (GTN),  which  includes  choriocarcinoma,  placental  site  trophoblastic  tumor  (PSTT),  and  epithelioid  trophoblastic  tumor  (ETT)  (1).  Invasive  moles  may  also  occur  and  are  best  categorized  as  malignant,  since  they  can  metastasize.  Gestational  trophoblastic  neoplasia  is  also  described  as  gestational  trophoblastic  tumor  (GTT)  and  is  further  designated  as  nonmetastatic  or  metastatic  (2).